GLP-1 agonists slow gastric emptying, which can modestly reduce iron uptake in the small intestine
EMERGE is a US based, multicenter, randomized, double-blind, placebo-controlled, repeat dose parallel group study with a 21-day run in and 28-day treatment period
Rapid weight loss can accelerate this process, impacting skin quality and resilience
Unlike some medications with circadian-dependent metabolism, B12 absorption mechanisms function consistently throughout the 24-hour cycle
Tirzepatide offers significant health benefits, including up to 15% body weight reduction over 68 weeks and a convenient once-weekly administration, which can simplify a patients weight management routine
inhibition of ferroptosis can effectively attenuate secondary injury after ICH and play a neuro-protective role